Cycloferon tab. p / o ksh / sol. 150mg # 20

Release form, composition and packaging

?

Enteric-coated yellow tablets, round, biconvex

cross section - yellow core.

1 tab.

meglumine acridone acetate (calculated as acridoneacetic acid) 150 mg

povidone - 7.93 mg, calcium stearate - 3.07 mg, hypromellose - 2.73 mg, polysorbate 80 - 0.27 mg, copolymer of methacrylic acid and ethyl acrylate - 23.21 mg, propylene glycol - 1.79 mg.

10 pieces.

- contour cell packaging (1) - cardboard packs.

10 pieces.

- contour cell packaging (5) - cardboard packs.

20 pcs.

- contour cell packaging (1) - cardboard packs.

pharmachologic effect

Cycloferon® is a low-molecular-weight interferon inducer, which determines a wide range of its biological activity (antiviral, immunomodulatory, anti-inflammatory).

Cycloferon® is effective against herpes viruses, influenza and other causative agents of acute respiratory diseases.

It has a direct antiviral effect, suppressing the reproduction of the virus in the early stages (1-5 days) of the infectious process, reducing the virulence of the viral progeny, leading to the formation of defective viral particles.

Increases the body's nonspecific resistance against viral and bacterial infections.

Pharmacokinetics

Absorption After taking the drug inside in a daily dose, Cmax in blood plasma is reached after 2-3 hours, the concentration gradually decreases by 8 hours, after 24 hours the active substance is found in trace amounts.

Excretion of T1 / 2 is 4-5 hours. The use of Cycloferon® in recommended doses does not create conditions for its accumulation in the body.

Indications for use

As part of complex therapy in adults: - influenza and acute respiratory diseases

- herpes infection.

As part of complex therapy for children aged 4 years and older: - influenza and acute respiratory diseases

- herpes infection.

Prevention of influenza and acute respiratory diseases in children aged 4 years and older.

Contraindications for use

- cirrhosis of the liver in the stage of decompensation

- children's age up to 4 years (due to the imperfect act of swallowing)

- pregnancy

- period of breastfeeding

- individual intolerance to the components of the drug.

The drug should be used with caution in diseases of the digestive system in the acute phase (erosion, gastric and / or duodenal ulcers, gastritis, duodenitis) and a history of allergic reactions.

Before taking the drug, patients with these diseases should consult a doctor.

Dosage regimen

The drug is taken orally 1 time / day 30 minutes before meals, without chewing, drinking 1/2 glass of water. The dose of the drug depends on the age of the patient. Adults and children over 12 years of age are prescribed 450-600 mg (3-4 tablets) per appointment. Children aged 7-11 years are prescribed 300-450 mg (2-3 tablets) per appointment. Children aged 4-6 years are prescribed 150 mg (1 tab.) For admission. It is advisable to repeat the course 2-3 weeks after the end of the first course. Adults In the treatment of influenza and acute respiratory diseases, the drug should be taken on days 1, 2, 4, 6, 8 (course of treatment - 20 tab.). Treatment should be started at the first symptoms of the disease. In case of severe flu, 6 tablets should be taken on the 1st day. drug. If necessary, symptomatic therapy is additionally carried out (antipyretic, analgesic, expectorant drugs).In case of herpes infection, the drug should be taken on 1, 2, 4, 6, 8, 11, 14, 17, 20, 23 days (course of treatment - 40 tab.) Treatment is most effective when the first symptoms of the disease appear. Children aged 4 years and older In the treatment of influenza and acute respiratory diseases, the drug should be taken in a dose appropriate for age, on the 1st, 2nd, 4, 6, 8, 11, 14, 17, 20, 23 days. The course of treatment is from 5 to 10 receptions, depending on the severityThe course of treatment is from 5 to 10 receptions, depending on the severityThe course of treatment is from 5 to 10 receptions, depending on the severity

Name ENG

CYCLOFERON

Clinical and pharmacological group

Antiviral and immunomodulatory drug.

Interferon synthesis inductor

ATX code

Other immunostimulants

Dosage

150mg

Structure

1 tablet contains 150 mg of methylglucamine acridone acetate.

Indications

Cycloferon is used in adults:

-in the treatment of influenza and other respiratory viral infections

- in the treatment of acute and chronic viral hepatitis (severe forms of hepatitis A, hepatitis B and C, cytomegalovirus hepatitis)

- in the treatment of herpes infection

-in the treatment of HIV infection (stages 1A-3B)

-in the complex therapy of neuroinfections (serous meningitis, tick-borne borreliosis (Lyme disease), multiple sclerosis, etc.)

-in the complex treatment of intestinal infections as a component of immunotherapy

- with secondary immunodeficiencies of various etiologies (early postoperative period, intensive cytostatic and hormonal therapy, chronic infections, neoplasms and other immunodeficiency states)

- as a means of immunoprophylaxis of carcinogenesis in high-risk groups (radiation damage, living in contaminated areas and other technogenic factors

INN / Active ingredient

acridoneacetic acid

Contraindications

Pregnancy, breastfeeding, liver cirrhosis.

In diseases of the thyroid gland, the use of cycloferon is carried out under the supervision of an endocrinologist.

Storage conditions and periods

In a dark place at a temperature not exceeding 25 degrees.

Expiration date: 2 years

Specifications

Category

Antiviral

,

Antimicrobial agents

Scope of the drug

General

Release form

Tablet

Manufacturer country

Russia

Package quantity, pcs

twenty

Minimum age from

4 years old

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Polisan

The amount of the dosage form in the primary package

20 pcs.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Immunostimulating agent

Anatomical and therapeutic characteristics

L03AX Other immunostimulants

Dosage form

Enteric-coated tablets

Expiration date in days

730

The target audience

Children

Package weight, g

25

Mode of application

:

The use of Cycloferon for emergency non-specific prophylaxis and treatment of influenza and other acute respiratory infections: the drug is taken orally once a day on an empty stomach according to the scheme: 1 day - 4 tablets at a time, on days 2, 4, 6 - 2 tablets.

In total for a course of 10 tablets (one pack) Cycloferon is used in adults orally once a day half an hour before meals, without chewing, according to the basic scheme, 2-4 tablets per reception in 1, 2, 4, 6, 8, 11, 14 , 17, 20, 23 days depending on the nature of the disease

Dosage (volume) of the substance in the preparation

:

Meglumine acridone acetate in terms of acridoneacetic acid - 150 mg

Information on technical characteristics, delivery set, country of manufacture